Esketamine is a new medication for the treatment of major depression. It is an injectable, non-opioid based medicine that has been shown to be effective in reducing depressive symptoms, even when other treatments have failed.
Esketamine is an active metabolite of ketamine, a drug that has been used for years as an anesthetic and sometimes as a street drug. Esketamine is not addictive and does not have the same abuse potential as ketamine.
The FDA approved Spravato (esketamine) in June 2019 for use in treating major depressive disorder (MDD) in adults who have failed to respond adequately to two or more antidepressants at therapeutic doses for their current episode. The approval was based on results from two clinical trials showing that Spravato improved depression symptoms within 1 week after treatment compared with placebo.
Spravato Treatment for Depression
Depression is a serious medical condition that affects about 1 in every 20 people. Although there are many effective medications for depression, many people do not respond adequately to the first drug they try. If you have tried antidepressants before and are still experiencing symptoms of depression, such as low mood or anxiety, it may be time to consider other treatment options.
Spravato (esketamine) is a new medication that has been approved by the FDA for the treatment of major depressive disorder (MDD). It belongs to a class of drugs called NMDA receptor antagonists, which work by blocking signals in the brain that may contribute to depression.
Spravato treatment centers
This medication has been studied in clinical trials as adjunctive therapy and has been found to be more effective when combined with an antidepressant than when used alone. It is important to understand, however, that it does not work for everyone – just like any other medication – so it may not be right for you if you have already tried other antidepressants without success.
Spravato has been found to be both safe and effective as an antidepressant medication; however, like any other medication it may have side effects such as nausea or vomiting which will lessen over time with continued use as your body adjusts itself to having higher levels of these chemicals circulating through its system
Author’s Bio
Dr. David Boguslavsky, MD, is a highly experienced family physician and medical acupuncturist with over two decades of clinical practice, who has emerged as a leader in mental health treatment, particularly in the field of depression. A graduate of Robert Wood Johnson Medical School, Dr. Boguslavsky is board-certified in both Family Medicine and Medical Acupuncture, showcasing his diverse medical expertise. His extensive experience spans a wide range of medical care, from acute illnesses to chronic condition management, with a particular focus on preventative care and pain treatment.Notably, Dr. Boguslavsky has pioneered innovative approaches to depression treatment, having administered over 10,000 Spravato treatments, establishing himself as one of the foremost experts in this cutting-edge therapy. His unique blend of traditional Western medicine, Eastern acupuncture techniques, and advanced psychiatric treatments allows him to offer comprehensive, personalized care to his patients at PremierMD and Spravato Treatment Centers of NJ. Fluent in English and Russian, Dr. Boguslavsky brings a multifaceted approach to healthcare, combining the latest medical technologies with time-honored principles of doctor-patient relationships to address both physical and mental health needs.
